Advertisement
Singapore markets open in 1 hour 46 minutes
  • Straits Times Index

    3,187.66
    +32.97 (+1.05%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Bitcoin USD

    63,607.81
    +1,951.64 (+3.17%)
     
  • CMC Crypto 200

    1,312.38
    +426.84 (+48.20%)
     
  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     
  • Gold

    2,394.00
    -4.00 (-0.17%)
     
  • Crude Oil

    82.56
    -0.17 (-0.21%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • Nikkei

    38,079.70
    +117.90 (+0.31%)
     
  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     
  • FTSE Bursa Malaysia

    1,544.76
    +4.34 (+0.28%)
     
  • Jakarta Composite Index

    7,166.81
    -7,130.84 (-49.87%)
     
  • PSE Index

    6,523.19
    +73.15 (+1.13%)
     

BeyondSpring, Inc. (BYSI) Q4 2021 Earnings Call Transcript

BeyondSpring, Inc. (BYSI) Q4 2021 Earnings Call Transcript

Joining us on today's call is Dr. Lan Huang, Beyond Spring's co-founder, chairman, and chief executive officer; Dr. Ramon Mohanlal, executive vice president, research and development, and chief medical officer; and Elizabeth Czerepak, chief financial officer. After the company response letter from the U.S. FDA last November, we took steps to streamline our operations in order to extend the cash runway. First, we are pleased with our ongoing discussions with China NMPA under review of plinabulin's NDA in combination with G-CSF for the prevention of chemotherapy-induced neutropenia, or CIN.